 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
The inappropriate use of high-priced agents such as human serum albumin significantly contributes to the rising cost of medical care. A utilization review was conducted at the University of Michigan Hospital in order to identify the appropriateness of use of this agent. Criteria were developed and prescribing was retrospectively evaluated for 81 patients. Of the 935 units administered to these patients, 692 (74 percent) were judged to be inappropriate. This inappropriate use accounted for a projected annual expenditure of nearly $281,000. Interventions have previously demonstrated success in improving prescribing.
This article has been cited by other articles:
|
|
 |
|
  G. A. Knoll, J. A. Grabowski, G. F. Dervin, and K. O'Rourke A Randomized, Controlled Trial of Albumin versus Saline for the Treatment of Intradialytic Hypotension J. Am. Soc. Nephrol., February 1, 2004; 15(2): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Boldt The Good, the Bad, and the Ugly: Should We Completely Banish Human Albumin from Our Intensive Care Units? Anesth. Analg., October 1, 2000; 91(4): 887 - 895. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
